Global blood therapeutics, inc. (GBT)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
Assets
Current assets:
Cash and cash equivalents

315,525

302,237

267,604

338,454

156,836

275,357

194,891

342,103

455,637

198,332

84,149

93,741

135,744

92,072

217,837

231,910

133,984

148,502

158,497

40,575

52,069

Short-term marketable securities

215,295

307,732

335,500

320,098

300,431

202,177

188,337

120,381

87,949

116,493

135,206

136,075

108,580

55,202

-

-

-

-

-

-

-

Accounts receivable, net

4,578

2,637

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

14,927

1,277

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

6,337

-

-

-

3,839

-

-

-

1,983

1,706

1,637

1,907

1,222

1,623

419

1,135

Prepaid expenses and other current assets

14,144

14,114

12,699

8,207

8,222

1,909

8,951

7,051

10,264

5,648

10,415

5,036

3,996

512

1,723

553

647

-

607

1,412

389

Total current assets

564,469

627,997

615,803

666,759

465,489

485,780

392,179

469,535

553,850

324,312

229,770

234,852

248,320

149,769

221,266

234,100

136,538

149,724

160,727

42,406

53,593

Property and equipment, net

37,329

27,113

14,337

12,345

13,090

14,981

16,749

17,097

17,414

16,571

13,169

5,200

2,373

2,420

2,626

2,562

2,293

2,114

2,168

2,182

2,023

Long-term marketable securities

84,378

85,030

80,000

73,176

117,811

114,281

98,869

51,487

992

14,607

40,073

60,779

65,936

50,058

-

-

-

-

-

-

-

Operating lease right-of-use assets

52,082

52,775

13,845

13,964

14,075

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

2,395

2,395

2,395

2,395

2,395

2,395

2,395

906

906

1,046

1,046

1,046

1,046

140

140

140

140

140

140

140

140

Other assets, noncurrent

493

789

968

193

200

206

219

213

214

184

-

-

-

-

-

-

-

-

-

-

-

Total assets

741,146

796,099

727,348

768,832

613,060

617,643

510,411

539,238

573,376

356,720

284,058

301,877

317,675

202,387

224,032

236,802

138,971

151,978

163,035

44,728

55,756

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

13,696

10,621

7,135

6,755

7,346

6,046

4,960

3,429

7,360

7,177

3,382

4,966

3,141

4,320

3,038

4,815

4,295

3,254

1,419

1,482

541

Payable due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

12

14

Accrued liabilities

34,562

41,358

22,198

23,369

17,757

16,792

13,844

10,628

11,220

10,135

6,317

6,586

7,916

5,319

5,863

4,838

4,738

3,411

3,006

2,155

948

Accrued compensation

11,269

17,578

10,450

8,241

5,629

10,036

7,179

6,240

4,723

8,579

5,521

4,492

2,775

4,967

3,351

2,856

1,715

2,242

1,447

782

847

Other liabilities, current

2,721

1,896

1,410

1,348

1,359

899

944

990

657

373

1,137

1,104

915

909

905

654

747

720

701

802

187

Total current liabilities

62,248

71,453

41,193

39,713

32,091

33,773

26,927

21,287

23,960

26,264

16,357

17,148

14,747

15,515

13,157

13,163

11,495

9,627

6,573

5,233

2,537

Long-term debt

73,688

73,559

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, noncurrent

81,638

72,359

23,691

24,048

24,401

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities, noncurrent

-

34

4,367

881

30

11,071

11,283

11,398

11,652

11,652

9,434

3,019

437

563

775

1,232

1,354

1,556

1,645

1,616

384

Total liabilities

217,574

217,405

69,251

64,642

56,522

44,844

38,210

32,685

35,612

37,916

25,791

20,167

15,184

16,078

13,932

14,395

12,849

11,183

8,218

6,849

2,921

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

Redeemable convertible preferred stock, $0.001 par value: zero and 69,363,168 shares authorized at December 31, 2015 and 2014, respectively; zero and 69,113,168 shares issued and outstanding at December 31, 2015 and 2014, respectively; aggregate liquidation preference of zero and $103,289 at December 31, 2015 and 2014, respectively.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

105,554

102,161

Stockholders' equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized as of March 31, 2020 (unaudited) and December 31, 2019; no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

-

0

Common stock, $0.001 par value, 150,000,000 shares authorized as of March 31, 2020 (unaudited) and December 31, 2019, respectively; 60,886,371 and 60,644,380 shares issued and outstanding as of March 31, 2020 (unaudited) and December 31, 2019, respectively

61

61

60

60

56

56

52

52

52

46

43

43

43

37

37

36

30

29

29

3

2

Additional paid-in capital

1,334,238

1,316,795

1,300,000

1,281,333

1,076,979

1,044,941

895,478

886,624

877,550

617,051

515,126

510,083

506,892

367,371

363,789

355,111

241,157

239,231

237,668

0

0

Accumulated other comprehensive income

1,215

754

978

1,191

576

-48

-381

-242

-325

-336

-197

-268

-179

-166

-

-

-

-

-

-

-

Accumulated deficit

-811,900

-738,916

-642,941

-578,394

-521,073

-472,150

-422,948

-379,881

-339,513

-297,957

-256,705

-228,148

-204,265

-180,933

-153,726

-132,740

-115,065

-98,465

-82,880

-67,678

-49,328

Total stockholders' equity

523,572

578,694

658,097

704,190

556,538

572,799

472,201

506,553

537,764

318,804

258,267

281,710

302,491

186,309

210,100

222,407

126,122

140,795

154,817

-67,675

-49,326

Total liabilities and stockholders' equity

741,146

796,099

727,348

768,832

613,060

617,643

510,411

539,238

573,376

356,720

284,058

301,877

317,675

202,387

224,032

236,802

138,971

151,978

163,035

44,728

55,756